Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Common Equity (2019 - 2026)

Viatris (VTRS) posted Common Equity of $14.3 billion for Q2 2026, down 2.71% on a QoQ basis from $14.7 billion in Q1 2026, and down 8.41% year-over-year from $15.6 billion in Q2 2025.

Analysis

Viatris (VTRS) Common Equity (2019 - 2026) Analysis & Trends

Viatris has reported Common Equity for 8 years, with the latest figure at $14.3 billion in Q2 2026.

  • On a quarterly basis, Common Equity fell 8.41% year-over-year to $14.3 billion in Q2 2026; TTM through Jun 2026 was $14.3 billion, a 8.41% decrease from a year earlier, with the FY2025 full-year figure at $14.7 billion, down 21.06% from the prior year.
  • Common Equity was $14.3 billion for Q2 2026 at Viatris, down from $14.7 billion in the prior quarter.
  • The five-year high for Common Equity was $21.1 billion in Q4 2022, with the low at $14.3 billion in Q2 2026.
  • Average Common Equity over 5 years is $18.4 billion, with a median of $19.7 billion recorded in 2024.
  • The sharpest annual moves came in 2023 and 2025: Common Equity grew 8.78% in 2023, then retreated 23.11% in 2025.
  • Over 5 years, Common Equity stood at $21.1 billion in 2022, then decreased by 2.87% to $20.5 billion in 2023, then retreated by 8.95% to $18.6 billion in 2024, then dropped by 21.06% to $14.7 billion in 2025, then declined by 3.06% to $14.3 billion in 2026.
  • The last three Common Equity figures came in at $14.3 billion (Q2 2026), $14.7 billion (Q1 2026), and $14.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 7.76 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 14.26 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 4.08 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 33.02 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -1.77 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -191.48 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 597.21 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 768.16 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 42.44 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 4.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.26 Bn
Mar 31, 2026 14.66 Bn
Dec 31, 2025 14.71 Bn
Sep 30, 2025 15.22 Bn
Jun 30, 2025 15.57 Bn
Mar 31, 2025 15.65 Bn
Dec 31, 2024 18.64 Bn
Sep 30, 2024 19.79 Bn
Jun 30, 2024 19.52 Bn
Mar 31, 2024 20.01 Bn
Dec 31, 2023 20.47 Bn
Sep 30, 2023 20.87 Bn
Jun 30, 2023 20.84 Bn
Mar 31, 2023 20.93 Bn
Dec 31, 2022 21.07 Bn
Sep 30, 2022 19.18 Bn
Jun 30, 2022 19.81 Bn
Mar 31, 2022 20.45 Bn
Dec 31, 2021 20.49 Bn
Sep 30, 2021 21.14 Bn